Granted Patent B2

US 8,034,595 · App. 11/868,909 · Granted Oct 11, 2011

Abstract

Claims (43)

1. An isolated, synthetic or recombinant polypeptide having a hydrolase activity and comprising an amino acid sequence:

(a) encoded by a nucleic acid having the sequence comprising SEQ ID NO: 1;

(b) encoded by a nucleic acid comprising a sequence having at least 95%, 97% or 99% or complete sequence identity to SEQ ID NO: 1;

(c) of the peptide as set forth in SEQ ID NO:2;

(d) having at least 95%, 97% or 99% or complete sequence identity to SEQ ID NO:2;

(e) of the polypeptide of any of (a) to (d) having a nitrilase activity;

(f) of the polypeptide of (e) having a nitrilase activity comprising the ability to produce an enantiomerically pure α-substituted carboxylic acid, α-amino acid or α-hydroxy acid;

(g) of the polypeptide of (e) having a nitrilase activity comprising the ability to stereoselectively hydrolyze a transient amino nitrile or cyanohydrin under Strecker conditions (in the presence of cyanide and ammonia);

(h) comprising an enzymatically active fragment of the polypeptide of any of (a) to (g);

(i) of the polypeptide of any of (a) to (h) further comprising an additional amino acid sequence; or

(j) of the polypeptide of (i), wherein the additional amino acid sequence comprises or consists of a secretory sequence; a proprotein sequence; or, a sequence which facilitates purification, enrichment, or stabilization of the polypeptide.

2. The isolated, synthetic or recombinant polypeptide of claim 1 comprising:

(a) at least one conservative amino acid substitution;

(b) the polypeptide of (a), wherein a conservative amino acid substitution comprises:

replacement of an aliphatic amino acid with another aliphatic amino acid, or replacement of an acidic residue with another acidic residue, or replacement of a residue bearing an amide group with another residue bearing an amide group, or exchange of a basic residue with another basic residue, or replacement of an aromatic residue with another aromatic residue; or

(c) the polypeptide of (b), wherein a conservative amino acid substitution comprises:

replacement of an alanine, valine, leucine or isoleucine with an alanine, valine, leucine or isoleucine; replacement of a serine with a threonine or vice versa; replacement of an aspartic acid or glutamic acid with another acidic residue; replacement of an asparagine or glutamine with another residue bearing an amide group; exchange of a lysine or arginine with another basic residue; or replacement of a phenylalanine or tyrosine with another aromatic residue.

3. The isolated, synthetic or recombinant polypeptide of claim 1 , further comprising, or contained in, a protein preparation, an extract or a biological sample.

4. The isolated, synthetic or recombinant polypeptide of claim 1 , wherein the hydrolase activity comprises the ability to produce an alpha-substituted carboxylic acid by a method comprising:

(A) (a) providing an aldehyde or a ketone;

(b) providing a cyanide-containing compound;

(c) providing an ammonia-containing compound or a compound comprising an ammonium salt or an amine;

(d) providing a composition comprising a nitrilase, wherein the nitrilase has the amino acid sequence of the polypeptide of claim 1 ;

(e) contacting the aldehyde or ketone of step (a) with a cyanide-containing compound step (b) and an ammonia-containing compound or a compound comprising an ammonium salt or an amine of step (e) such that an amino nitrile or a cyanohydrin intermediate is produced; and

(f) contacting the amino nitrile or cyanohydrin intermediate of step (e) with the composition of step (d) such that the nitrilase hydrolyzes the amino nitrile or cyanohydrin intermediate to produce an alpha-substituted carboxylic acid,

wherein the α-substituted carboxylic acid has the following structure:

wherein:

R 1 and R 2 are each independently —H, substituted or unsubstituted alkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl, heterocyclic, wherein the substituents are lower alkyl, hydroxyl, alkoxy, mercapto, cycloalkyl, heterocyclic, aryl, heteroaryl, aryloxy, or halogen or optionally R 1 and R 2 are linked to cooperate to form a functional cyclic moiety, and

E is —N(R x ) 2 or —OH, wherein each R x is each independently —H or a lower alkyl;

(B) the method of (A), wherein the hydrolase activity comprises the ability to stereoselectively produce an enantiomerically pure α-substituted carboxylic acid having the following structure:

wherein:

R 1 and R 2 are each independently —H, substituted or unsubstituted alkyl, alkenyl, alkylnyl, aryl, heteroaryl, cycloalkyl, heterocyclic, wherein the substituents are lower alkyl, hydroxyl, alkoxy, mercapto, cycloalkyl, heterocyclic, aryl, heteroaryl, aryioxy, or halogen or optionally R 1 and R 2 are linked to cooperate to form a functional cyclic moiety, and

E is —N(R x ) 2 or —OH, wherein each R x is —H or lower alkyl;

(C) the method of (B), wherein the enantiomerically pure α-substituted carboxylic acid is an α-amino acid;

(D) the method of any of (A) to (C), wherein at least one of R 1 and R 2 is a substituted or unsubstituted aryl;

(E) the method of (C) or (D), wherein the enantiomerically pure α-amino acid is D-phenylalanine, D-phenylglycine, or L-methylphenylglycine;

(F) the method of (C) or (D), wherein the enantiomerically pure α-amino acid bears a substituted or unsubstituted alkyl side chain;

(G) the method of any of (C) to (F), wherein the enantiomerically pure α-amino acid is L-tert-leucine, D-alanine, or D-hydroxynorleucine;

(H) the method of any of (A) to (D), wherein the enantiomerically pure α-substituted carboxylic acid is an α-hydroxy acid;

(I) the method of any of (A) to (D), wherein the enantiomerically pure α-hydroxy acid is (S)-cyclohexymandelic acid, mandelic acid or 2-chloro mandelic acid;

(J) the method of any of (A) to (I), wherein the cyanide is a metal cyanide or a gaseous cyanide, or the cyanide is an alkali cyanide, or the metal cyanide is sodium cyanide;

(K) the method of any of (A) to (J), wherein the ammonium salt has the formula NH 2 (R) 2 + X, wherein each R is independently —H or lower alkyl, and X is a counter ion; or

(L) the method of (K), wherein X is a halide and/or the halide is Cl 31 , or the ammonium salt is NH 4 30 Cl 31 .

Assignments (6)